Stockscreener 앱 받기
2.23
0.00%
0.00
시장 영업 전:
2.15
-0.08
-3.59%
전일 마감가:
$2.23
열려 있는:
$2.25
하루 거래량:
41,095
Relative Volume:
0.72
시가총액:
$6.73M
수익:
$4.88M
순이익/손실:
$-3.66M
주가수익비율:
-1.4532
EPS:
-1.5345
순현금흐름:
$-2.80M
1주 성능:
-2.19%
1개월 성능:
-13.23%
6개월 성능:
-27.36%
1년 성능:
-72.94%
1일 변동 폭
$2.15
$2.29
1주일 범위
$2.14
$2.29
52주 변동 폭
$2.11
$8.40
Biomerica Inc Stock (BMRA) Company Profile
명칭
Biomerica Inc
전화
(949) 379-2875
주소
17571 VON KARMAN AVENUE, IRVINE, CA
Compare BMRA vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BMRA
Biomerica Inc
|
2.23 | 6.73M | 4.88M | -3.66M | -2.80M | -1.5345 |
|
ABT
Abbott Laboratories
|
113.29 | 195.21B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
377.32 | 141.28B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
98.49 | 123.60B | 35.48B | 4.64B | 5.41B | 3.5856 |
|
BSX
Boston Scientific Corp
|
76.28 | 113.14B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.98 | 45.52B | 6.07B | 1.06B | 799.60M | 1.8527 |
Biomerica Inc Stock (BMRA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-11-10 | 개시 | Colliers Securities | Buy |
| 2018-01-04 | 개시 | B. Riley FBR, Inc. | Buy |
Biomerica Inc 주식(BMRA)의 최신 뉴스
Vietnam Approves Biomerica's Ez Detect?? for Nationwide Distribution - marketscreener.com
Biomerica (BMRA) Expands in Vietnam with Approval of EZ Detect T - GuruFocus
Vietnam approves Biomerica’s at-home colorectal cancer screening test - Investing.com
Biomerica Receives Approval for EZ Detect™ Colorectal Disease Test in Vietnam, Expanding Access to At-Home Cancer Screening - Quiver Quantitative
At-home colon cancer test EZ Detect cleared for nationwide use in Vietnam - Stock Titan
Vietnam Approves Biomerica's EZ Detect for Nationwide Distribution - Bitget
Biomerica, Inc. (NASDAQ:BMRA) Sees Significant Decline in Short Interest - Defense World
What is the next catalyst for Biomerica Inc.Exit Point & Free Long-Term Investment Growth Plans - mfd.ru
Is Biomerica Inc. stock supported by strong fundamentalsWeekly Market Report & Fast Exit and Entry Strategy Plans - mfd.ru
Why analysts upgrade Biomerica Inc. stockJuly 2025 Setups & Long-Term Capital Growth Strategies - mfd.ru
Is Biomerica Inc. a good stock for dollar cost averaging2025 Top Gainers & Precise Entry and Exit Recommendations - mfd.ru
Growth Review: Is Biomerica Inc. being accumulated by smart moneyEarnings Summary Report & Fast Moving Stock Trade Plans - mfd.ru
Sell Signal: Is Biomerica Inc stock a value trapWeekly Stock Recap & Comprehensive Market Scan Reports - baoquankhu1.vn
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
What are the future prospects of Biomerica IncWeekly Gains Summary & Precise Swing Trade Entry Alerts - baoquankhu1.vn
Trend Recap: Is Biomerica Inc being accumulated by smart moneyQuarterly Profit Summary & Smart Swing Trading Alerts - baoquankhu1.vn
Short Covering: What is the next catalyst for Biomerica IncDip Buying & Daily Volume Surge Trade Alerts - baoquankhu1.vn
Should value investors consider Biomerica Inc2025 Trading Volume Trends & Free Verified High Yield Trade Plans - baoquankhu1.vn
Short Covering: Is Biomerica Inc stock risky to hold nowWeekly Stock Analysis & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Macro Review: Is Biomerica Inc backed by strong institutional buying2025 Breakouts & Breakdowns & Technical Pattern Alert System - baoquankhu1.vn
US-based Biomerica reports net sales of USD 1.21M in Q2 2026 - Medical Buyer
Biomerica Reports Second Quarter Fiscal 2026 Financial Results - The Manila Times
Medical diagnostics firm Biomerica's Q2 revenue falls amid product transition - TradingView — Track All Markets
BIOMERICA INC SEC 10-Q Report - TradingView
Medicare sets $300 price for IBS test as Biomerica expands AI diet tool - Stock Titan
Short Interest in Biomerica, Inc. (NASDAQ:BMRA) Expands By 123.2% - Defense World
Bullfrog AI Holdings, Inc. (NASDAQ:BFRGW) Short Interest Update - Defense World
Earnings Miss: Is Biomerica Inc stock risky to hold nowPortfolio Update Summary & AI Based Trade Execution Alerts - baoquankhu1.vn
How interest rate cuts could boost Biomerica Inc. stockPortfolio Value Summary & Free Verified High Yield Trade Plans - Улправда
Will Biomerica Inc. stock maintain dividend yield2025 Key Highlights & Expert Approved Momentum Ideas - Улправда
Is Biomerica Inc. stock safe for conservative investorsBuy Signal & Reliable Breakout Forecasts - Улправда
Can Captivision Inc. stock deliver strong Q4 earningsTreasury Yields & Daily Entry Point Trade Alerts - Улправда
How Biomerica Inc. stock responds to policy changesInsider Selling & Weekly Setup with ROI Potential - Улправда
How supply chain issues affect Rain Enhancement Technologies Holdco Inc. Equity Warrant stockQuarterly Portfolio Report & Risk Adjusted Swing Trade Ideas - Улправда
Why CRVS stock is rated strong buyWeekly Gains Summary & Fast Moving Market Watchlists - Улправда
Will Bulten AB (publ) (3FB) stock return to pre crash levels2025 Dividend Review & Technical Entry and Exit Tips - Улправда
Targets Report: Why Adams Natural Resources Fund Inc. stock remains stableWeekly Investment Recap & Risk Controlled Stock Alerts - Улправда
Is The Vita Coco Company Inc. stock trading at a premium valuationIPO Watch & Safe Capital Growth Plans - Улправда
Zodiac Energy Limited (ZODIAC) Signs Major DealGap Up/Gap Down Analysis & Budget Friendly Trading Strategies - bollywoodhelpline.com
Biomerica Adds Most New Retail Followers Among Biotechs After UAE Nod For Prostate Cancer Screening Test - MSN
Biomerica (NASDAQ:BMRA) Stock Crosses Below Two Hundred Day Moving Average – Time to Sell? - Defense World
Biomerica (BMRA) Stock Analysis Report | Ratings, Financials & Performance - Benzinga España
Biomerica stock soars after Medicare sets $300 payment rate for IBS test - Investing.com Australia
Medicare to pay $300 for Biomerica’s IBS test starting January 2026 - Investing.com Nigeria
Biomerica Gains Exposure as Distribution Expands in Egypt - StocksToTrade
Biomerica’s Market Presence Expands with Egyptian Drug Authority Authorization - timothysykes.com
Biomerica stock soars after Medicare sets $300 payment rate for IBS test By Investing.com - Investing.com Nigeria
Medicare to pay $300 for Biomerica’s IBS test starting January 2026 By Investing.com - Investing.com South Africa
Biomerica, Inc. Announces Medicare Payment Rate for inFoods® IBS Test Set at $300 Effective January 1, 2026 - Quiver Quantitative
Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test - The Manila Times
Biomerica announces CMS Medicare payment rate of $300 for revolutionary Infoods® IBS test - marketscreener.com
Biomerica Inc (BMRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.13%
자본화:
|
볼륨(24시간):